UK EC ruling
This article was originally published in The Tan Sheet
Executive Summary
UK judge rules emergency contraception can continue to be lawfully supplied by a physician or over-the-counter in pharmacies, Department of Health announces April 18. Society for Protection of the Unborn Child applied for Judicial Review of ECs, alleging they cause abortions and should not be legally administered. The case was heard Feb. 12-14; the judge found SPUC's legal argument to be "erroneous" and dismissed application. Case hinged on definition of when pregnancy begins; established medical view in the UK is that pregnancy begins at implantation and not when an egg is fertilized. EC works before implantation and cannot take effect if taken post implantation...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.